Renaissance Technologies - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 46 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2017. The put-call ratio across all filers is 4.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$12
-50.0%
60,800
-12.4%
0.00%
Q1 2023$24
-11.1%
69,381
-16.2%
0.00%
Q4 2022$27
-99.7%
82,800
+319.4%
0.00%
Q2 2022$9,000
-94.6%
19,742
-70.8%
0.00%
Q4 2020$168,000
+90.9%
67,564
+88.2%
0.00%
Q3 2020$88,000
-58.3%
35,900
-39.5%
0.00%
Q2 2020$211,000
-13.9%
59,375
-43.3%
0.00%
Q1 2020$245,000
+214.1%
104,700
+193.4%
0.00%
Q4 2019$78,000
+122.9%
35,681
+84.0%
0.00%
Q3 2019$35,000
+59.1%
19,390
+30.1%
0.00%
Q2 2019$22,000
-90.8%
14,900
-72.7%
0.00%
Q2 2017$240,00054,5000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2017
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders